Papers by Elliott M. Antman
Page 1 · newest first
- Interpretable multimodal network analysis of lipid‐lowering therapiesBritish Journal of Pharmacology · 2026
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of FallingJournal of the American College of Cardiology · 2016
- Eugene Braunwald Legacy Series: Building a Framework for Academic MedicineCirculation · 2026
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJournal of the American College of Cardiology · 1998
- SYNTAX Score and Long-Term OutcomesJournal of the American College of Cardiology · 2017
- ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org.Journal of the American College of Cardiology · 2001
- ACCF/AHA Clinical Practice Guideline Methodology Summit ReportCirculation · 2012
- A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskJournal of the American College of Cardiology · 2025
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary ArticleJournal of the American College of Cardiology · 2005
- Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver DiseaseJournal of the American College of Cardiology · 2019
- ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive SummaryJournal of the American College of Cardiology · 2003
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation · 2004
- ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac DeathJournal of the American College of Cardiology · 2006
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionJournal of the American College of Cardiology · 2008
- Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortalityJournal of the American College of Cardiology · 2003
- Development of Systems of Care for ST-Elevation Myocardial Infarction PatientsCirculation · 2007
- PrasugrelCirculation · 2010
- Third Universal Definition of Myocardial InfarctionJournal of the American College of Cardiology · 2012
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)American Heart Journal · 2010
- Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial FibrillationJournal of the American College of Cardiology · 2024
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation · 2006
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarctionJournal of the American College of Cardiology · 2000
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)Journal of the American College of Cardiology · 2009
- The Aspirin-NSAID InteractionJournal of the American College of Cardiology · 2018
- The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient OutcomesCirculation · 2006
- Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 TrialJournal of the American College of Cardiology · 2007
- ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary articleJournal of the American College of Cardiology · 2003
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology · 2000
- Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trialsJournal of the American College of Cardiology · 1998
- ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac SurgeryJournal of the American College of Cardiology · 2007
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID UseJournal of the American College of Cardiology · 2008
- Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AFEuropean Heart Journal · 2024
- ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID UseJournal of the American College of Cardiology · 2010
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseJournal of the American College of Cardiology · 2006
- ACC/AHA 2002 guideline update for exercise testing: summary articleJournal of the American College of Cardiology · 2002
- B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarctionJournal of the American College of Cardiology · 2004
- ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summaryJournal of the American College of Cardiology · 2002
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology · 2001
- Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-MakingJACC Advances · 2025
- Polygenic risk score for coronary artery disease across the spectrum of atherosclerotic diseaseEuropean Journal of Preventive Cardiology · 2025
- A polygenic risk score for peripheral artery disease and major adverse limb eventsEuropean Heart Journal · 2025
- Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF‐TIMI 48 TrialJournal of the American Heart Association · 2025
- Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial FibrillationJAMA Cardiology · 2024
- Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentationBMC Infectious Diseases · 2024
- Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial FibrillationCirculation Cardiovascular Quality and Outcomes · 2024
- Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic StenosisJAMA Cardiology · 2024
- Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationCirculation · 2024
- Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USASHILAP Revista de lepidopterología · 2023
- Serial Assessment of Biomarkers and Heart Failure Outcomes in Patients with Atrial FibrillationEuropean Journal of Heart Failure · 2023
- Privacy-aware multi-institutional time-to-event studiesPLOS Digital Health · 2022